Clustering data with hclust algorithm for (Study ST002097)
Reversed phase NEGATIVE ION MODE (Analysis AN003427)| Metabolite | Structure | F1 | F2 | F3 | F4 | F5 | F6 |
|---|---|---|---|---|---|---|---|
| L-Lactate | ME510712 | 0.90 | 1.20 | 1.00 | 1.27 | 0.83 | 0.81 |
| p-Hydroxyphenylpropionic acid | ME510726 | 0.88 | 1.18 | 1.06 | 1.03 | 0.90 | 0.96 |
| D-Fructose | ME510722 | 0.93 | 1.17 | 1.06 | 1.37 | 0.77 | 0.69 |
| Malonic acid | ME510714 | 1.21 | 0.57 | 0.88 | 0.92 | 1.08 | 1.34 |
| Indoxyl sulfate | ME510718 | 0.87 | 1.09 | 1.19 | 1.33 | 0.88 | 0.63 |
| Oxalic acid | ME510713 | 0.94 | 1.20 | 0.99 | 1.19 | 0.84 | 0.83 |
| D-Glucose 6-phosphate | ME510719 | 0.65 | 1.51 | 1.22 | 1.57 | 0.62 | 0.43 |
| Glucose | ME510725 | 0.96 | 1.17 | 1.05 | 1.33 | 0.76 | 0.73 |
| Docosahexaenoic acid | ME510727 | 0.99 | 1.01 | 0.94 | 0.92 | 0.94 | 1.20 |
| Flavin adenine dinucleotide | ME510720 | 1.21 | 0.87 | 0.90 | 0.81 | 1.08 | 1.14 |
| Azelaic acid | ME510715 | 1.40 | 0.69 | 1.04 | 0.78 | 1.09 | 1.02 |
| Citrate | ME510702 | 0.55 | 0.91 | 0.80 | 1.09 | 0.99 | 1.66 |
| Citraconic acid | ME510706 | 0.14 | 1.17 | 0.58 | 2.16 | 0.78 | 1.17 |
| Allantoin | ME510717 | 0.46 | 1.13 | 0.67 | 0.82 | 1.04 | 1.87 |
| Gluconic acid | ME510724 | 1.23 | 0.96 | 0.79 | 0.78 | 1.29 | 0.95 |
| Succinic acid | ME510723 | 1.03 | 0.95 | 1.08 | 1.00 | 1.04 | 0.89 |
| Glutaric acid | ME510728 | 0.57 | 1.07 | 1.05 | 1.10 | 1.53 | 0.69 |
| Isocitric acid | ME510704 | 0.54 | 0.93 | 0.85 | 1.05 | 1.03 | 1.59 |
| Malic acid | ME510721 | 0.42 | 1.27 | 0.83 | 1.05 | 0.97 | 1.46 |
| Glycocholic acid | ME510707 | 1.11 | 1.00 | 1.34 | 0.94 | 0.92 | 0.69 |
| Methylmalonic acid | ME510710 | 1.01 | 0.95 | 1.07 | 1.01 | 1.05 | 0.91 |
| N-Acetylglutamic acid | ME510716 | 0.86 | 1.14 | 1.06 | 1.01 | 1.07 | 0.87 |
Factors:
| F1 | Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection (10 mL/kg of olive oil) |
| F2 | Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 10% CCl4 (10 mL/kg of olive oil) |
| F3 | Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 1% CCl4 (10 mL/kg of olive oil) |
| F4 | Treatment:3 times per week with 4 consecutive respectively intraperitoneal injection with 5% CCl4 (10 mL/kg of olive oil) |
| F5 | Treatment:Only intraperitoneally (i.p) injected with 1% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil. |
| F6 | Treatment:Only intraperitoneally (i.p) injected with 5% CCl4 (10 mL/kg, dissolved in olive oil) at the 12th injection. During the previous 11 times they were treated the same as the healthy controls with an equal volume of olive oil. |